Sponsor Pipeline

Crystalys Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
2
Phase 3
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-31 NCT07089888
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout		 Trial sites expanded: 86 -> 89 locations
2026-07-31 NCT07089875
A Study of Dotinurad Versus Allopurinol in Participants With Gout		 Trial sites expanded: 100 -> 103 locations
2026-07-31 NCT07535034
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase…		 Trial sites expanded: 17 -> 29 locations
Active Trials by Phase
Phase 3
2
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07089875 A Study of Dotinurad Versus Allopurinol in Participants With Gout Gout Recruiting
NCT07089888 A Study of Dotinurad Versus Allopurinol in Tophaceous Gout Tophaceous Gout Recruiting
Phase 2
NCT07535034 A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase… Gout Recruiting
Get alerts when Crystalys Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free